Zymeron Corporation
Biotechnology + Life Sciences
Zymeron, a preclinical pharmaceutical startup, is dedicated to developing myeloprotective and cardioprotective drugs that maintain the health and function of the circulatory system. MyeloShield is a target drug delivery system with controlled release of myeloprotective molecules to bone marrow shielding hematopoietic stem cells from radiation and chemotherapy.